Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer

Carobene A., Guerra E., Locatelli M., Cucchiara V., Briganti A., Aarsand A. K., ...More

CLINICA CHIMICA ACTA, vol.486, pp.185-191, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 486
  • Publication Date: 2018
  • Doi Number: 10.1016/j.cca.2018.07.043
  • Journal Name: CLINICA CHIMICA ACTA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.185-191
  • Keywords: Biological variation, Analytical performance specification, Prostate specific antigen, Prostate cancer, REFERENCE CHANGE VALUES, LABORATORY MEDICINE, CLINICAL-CHEMISTRY, QUALITY SPECIFICATIONS, STORAGE-CONDITIONS, SERUM, VARIABILITY, COLLECTION, VOLUNTEERS, FEDERATION
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

Background: Prostate-specific antigen (PSA) is central in the diagnosis of prostate cancer. However, high-quality biological variation (BV) estimates for PSA are scarce. Here BV estimates from the European Biological Variation Study (EuBIVAS) for total (tPSA), free (fPSA), conjugated PSA (cPSA), and percent free PSA (%fPSA) are provided.